… signal pathways or target genes to regulate drug susceptibility. Thus, it is advised that
miR-30a could be regarded as a promising biomarker and potential therapeutic target in cancer …

… This review article discusses the evidence for the potential role of c-MET as a biomarker
and therapeutic target in cancer, especially non-small cell lung carcinoma (NSCLC). …

… , and thus may provide potential biomarkers and/or therapeutic targets. Recently, we suggested
… as both a biomarker and a druggable therapeutic target with promising clinical potential. …

… use of HDL as a biomarker and may also lead to new therapeutic targets and therapies. …
The important clinical implications of the persistent elevations of these plasma biomarkers in …

Critical illness is characterized by disruptions in homeostasis that result in single-or multiple-organ
injury and reversible or irreversible organ dysfunction. To a large extent, the duration …

… serve as a potential therapeutic target and promising biomarker in … of miR-29a and its potential
application in the diagnosis, … as a potential therapeutic target and promising biomarker in …

… participated in tumor biology and affected the clinical treatment, therefore, we suggested that
miR-27a acted as a promising biomarker and potential therapeutic target in various tumors. …

… of MMPs in human cancers is as potential cancer biomarkers, both diagnostic and prognostic.
Below … We have specifically included those biomarkers for which validation studies have …

… that FAM3C is a novel biomarker and potential therapeutic target for various cancers. …
identify FAM3C as a novel clinical biomarker and a potential therapeutic target for cancers. …

… After that, a detailed discussion about this miRNA and also their targets in CRC … the potential
utilization of miR-196 and its targets as therapeutic targets and novel biomarkers in early …